Diversity in Clinical Trials Bill

Official: NIH Clinical Trial Integrity Act

IntroducedDecember 18, 2025

Why This Matters

The NIH Clinical Trial Integrity Act aims to ensure that clinical trials include a diverse range of participants, making research results more applicable to the general population. This is important for improving health outcomes for everyone.

If you participate in clinical trials, your experience may become easier and more inclusive of different backgrounds.

Affects: Patients with various health conditions, especially those from underrepresented racial and ethnic groups.

What changes is this bill making?

1. This bill requires clinical trials to include diverse participants based on race, ethnicity, age, and sex. 2. Sponsors must set clear goals for recruiting and keeping participants from different backgrounds. 3. The bill mandates a detailed plan for how trials will meet these diversity goals. 4. It encourages less burdensome follow-up options for trial participants, like virtual visits. 5. Researchers must receive training on how to include diverse groups in their studies.

Who is affected?

Patients with various health conditions, especially those from underrepresented racial and ethnic groups.